A detailed history of Lmr Partners LLP transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Lmr Partners LLP holds 3,100 shares of ASND stock, worth $385,578. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,100
Previous 10,000 69.0%
Holding current value
$385,578
Previous $1.36 Million 66.1%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$113.0 - $153.43 $779,700 - $1.06 Million
-6,900 Reduced 69.0%
3,100 $462,000
Q2 2024

Aug 14, 2024

BUY
$121.07 - $153.67 $1.21 Million - $1.54 Million
10,000 New
10,000 $1.36 Million

Others Institutions Holding ASND

About Ascendis Pharma A/S


  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $6.94B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.